Financials
- Market Capitalization 27.42 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
29.98
売上高対価格比率
12.37
1株当たり配当金
0.47
配当利回り(%)
4
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 355 | RVMD Revolution Medicines, Inc. - Common Stock | 205.57 USD | -1.11% | -4.06% | +11.46% | +271.06% | 44.06 B USD | ||
| 438 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 240.69 USD | +1.51% | +1.75% | +15.69% | -46.01% | 32.21 B USD | ||
| 491 | INSM Insmed Incorporated - Common Stock | 121.82 USD | +2.77% | -2.14% | +24.05% | -24.83% | 26.60 B USD | ||
| 511 | ROIV Roivant Sciences Ltd. - Common Shares | 34.64 USD | -0.20% | -6.18% | +4.40% | +89.19% | 25.02 B USD |